Effectiveness of sofosbuvir/velpatasvir and elbasvir/grazoprevir for the treatment of HCV genotype 1

Updated: Dec 15, 2020

Effectiveness of sofosbuvir/velpatasvir and elbasvir/grazoprevir for the treatment of HCV genotype 1 infection in a real-world cohort with numerous people who use drugs (PWUD)


Presented at the American Association of the Study of Liver Diseases, November 8-12, Boston, U.S.A, 2019.





© 2020 by Vancouver Infectious Diseases Centre. 

logo%20png_edited.png